Schroder Investment Management Group
AMED

Schroder Investment Management Group’s Amedisys AMED Stock Holding History

Schroder Investment Management Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-570,379
Closed -$42M – 1225
2023
Q1 		$42M Buy
570,379
+99,219
+21% +$8.58M 0.06% 316
2022
Q4 		$39.4M Sell
471,160
-67,464
-13% -$6.08M 0.06% 307
2022
Q3 		$52.1M Buy
538,624
+56,960
+12% +$6.79M 0.09% 240
2022
Q2 		$50.6M Buy
481,664
+72,956
+18% +$9.32M 0.08% 253
2022
Q1 		$70.7M Buy
408,708
+220,825
+118% +$33M 0.09% 216
2021
Q4 		$30.4M Buy
187,883
+169,770
+937% +$27.3M 0.04% 384
2021
Q3 		$2.7M Sell
18,113
-16,930
-48% -$3.52M ﹤0.01% 915
2021
Q2 		$8.58M Buy
35,043
+2,191
+7% +$575K 0.01% 715
2021
Q1 		$8.7M Buy
32,852
+4,018
+14% +$1.13M 0.01% 699
2020
Q4 		$8.46M Buy
28,834
+546
+2% +$140K 0.01% 674
2020
Q3 		$6.61M Sell
28,288
-855
-3% -$194K 0.01% 674
2020
Q2 		$5.79M Hold
29,143
– – 0.01% 657
2020
Q1 		$5.37M Sell
29,143
-9,670
-25% -$1.72M 0.01% 657
2019
Q4 		$6.48M Hold
38,813
– – 0.01% 709
2019
Q3 		$5.01M Buy
38,813
+949
+3% +$124K 0.01% 754
2019
Q2 		$4.6M Sell
37,864
-42,674
-53% -$5.06M 0.01% 706
2019
Q1 		$9.93M Sell
80,538
-9,461
-11% -$1.19M 0.02% 583
2018
Q4 		$10.5K Buy
+89,999
New +$10.6M 0.02% 541
2013
Q3 		– Sell
-315,600
Closed -$3.66M – 1507
2013
Q2 		$3.66M Buy
+315,600
New +$3.62M 0.01% 801

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Schroder Investment Management Group's AMED Position: Q2 2023 in Review

Schroder Investment Management Group sold out of Amedisys (AMED) in Q2 2023, closing a stake of 570,379 shares — an estimated $42M sold.

Schroder Investment Management Group first reported a position in AMED in Q2 2013 and held it in 19 quarters. The position peaked at $70.7M in Q1 2022. 301 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

  • Schroder Investment Management Group reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
  • Schroder Investment Management Group sold 570,379 Amedisys shares in Q2 2023, an estimated $42M.
  • Schroder Investment Management Group first reported a position in Amedisys in Q2 2013 and held it in 19 quarters.
  • Schroder Investment Management Group's Amedisys position peaked at $70.7M in Q1 2022.
  • 301 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Schroder Investment Management Group's 13F filing for Q2 2023, filed 11 Aug 2023.